Randomized, placebo-controlled trial of tolvaptan, a novel V2-receptor antagonist, in hyponatremia: Results of the SALT 2 trial with emphasis on efficacy and safety in cirrhosis Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Afdhal, N
  • Cardenas, A
  • Gines, P
  • Gross, Peter Lawrence
  • Verbalis, J
  • Berl, T
  • Schrier, R
  • Bichet, D
  • Wagoner, L
  • Ouyang, J
  • Orlandi, C
  • Czerwiec, F

publication date

  • October 1, 2005